15 employees
BioCanRx deals with translation, manufacture and adoption of cancer immunotherapies.
$675K sweet spot round size
Most of their 1 investments are in rounds between $675K and $675K
2014
Forbius raised $675K on February 2, 2018
Investors: BioCanRx